Select a country for a better browsing experience.

  • Global
open

All rights reserved.
©2025

Select a language.

ENopen ESopen FRopen
Want to go back?

Veterinary analysis

Key biochemical markers for monitoring diabetes in dogs and cats

Routine measurement of fructosamine, β-hydroxybutyrate (BHB) and non-esterified fatty acids (NEFA) provides a reliable and proactive approach to monitoring diabetes mellitus and the efficacy of its treatment in dogs and cats. These markers offer more stable and comprehensive insights than single glucose measurements and support early intervention and treatment adjustments.

What is diabetes mellitus?

Diabetes mellitus is a common endocrine disorder in companion animals, particularly in middle-aged and senior dogs and cats, caused by the body's inability to produce or use insulin.

It represents a growing challenge in veterinary medicine, due to the increase in the life expectancy of pets, the prevalence of obesity, and changes in the lifestyles of companion animals. It is estimated that one in every 300 dogs and cats will develop diabetes mellitus during their lifetime.

Its importance lies not only in its frequency, but also in the serious complications it can cause if not treated in time. This disease, considered chronic but manageable, requires early detection, continuous monitoring, and commitment from the owner and veterinary team. Therefore, owner education, preventive check-ups, and timely diagnosis are fundamental pillars for improving the quality and duration of life of diabetic patients.

Diabetes in companion animals is not only a clinical problem, but also an opportunity to strengthen the link between preventive medicine and animal welfare.

Diabetes in dogs

•  Most common type:  Type I diabetes (insulin-dependent).

•  Common causes:  Autoimmune destruction of pancreatic beta cells, chronic pancreatitis, genetic predisposition, obesity.

•  Common symptoms:  Polyuria (increased urination), polydipsia (increased water consumption), weight loss, polyphagia (Increased appetite) and lethargy.

Diabetes in cats

•  Most common type:  Type II diabetes (insulin resistance).

•  Predisposing factors:  Obesity, inactivity, advanced age, use of glucocorticoids, concurrent diseases.

•  Common symptoms:  Polyuria (increased urination), polydipsia (increased water consumption), weight loss and polyphagia (increased appetite). In advanced cases, weakness in hind limbs (diabetic neuropathy).

Importance of early diagnosis

•  Prevents serious complications: Such as diabetic ketoacidosis, which can be fatal, recurrent infections, cataracts (in dogs) and neuropathies (in cats).

•  Improves prognosis: Early treatment stabilises the patient and, in cats, can even achieve clinical remission in some cases.

•  Improves quality of life: Early glucose control helps keep the animal active, in good physical condition and with fewer clinical signs.

•  Reduces long-term cost: Detecting and treating diabetes before serious complications occur avoid costly hospitalisations.

It is crucial that veterinarians educate guardians about clinical signs and perform regular check-ups, especially in animals with risk factors such as obesity or advanced age.

At BioSystems, we specialise in veterinary analysis and recommend measuring three blood parameters that are important biomarkers for diagnosing and monitoring diabetes in pets:

Fructosamine

The fructosamine concentration reflects the average blood glucose level in the 2-3 weeks prior to the measurement, by measuring glycated serum proteins, primarily albumin. Unlike glucose, fructosamine does not increase simply due to stress, which is usual in veterinary visits and during blood sample collection.

Why test it?
- Helps distinguish between transient hyperglycemia (e.g., due to stress) and persistent hyperglycemia.
- Ideal for long-term monitoring of glycemic control in treated animals.

Reference range:
- Dogs: 0.225 - 0.365 mmol/L
- Cats: 0.190 - 0.365 mmol/L

High fructosamine values, in combination with elevated glucose and other clinical symptoms, may indicate a diagnosis of diabetes mellitus. Low values, on the other hand, are related to hypoglycemia. In the case of animals subjected to insulin treatment, values outside the reference ranges indicate poor glycemic control and require a revision of the insulin dose.

β-Hydroxybutyrate (BHB)

BHB is the main ketone body in blood and the most sensitive marker for detecting ketosis and early diabetic ketoacidosis (DKA), even before it appears in urine.

Why test it?
- Detects early metabolic decompensation.
- Useful in patients showing lethargy, anorexia, vomiting, or unexplained weight loss.

Reference range:
- < 0.4 mmol/L (dogs and cats)
- Suspicion of ketosis: > 0.8 mmol/L
- DKA likely: > 2.0 mmol/L

Non-esterified fatty acids (NEFA)

NEFAs are released when the body mobilizes fat as an energy source, typically due to insulin deficiency or prolonged fasting.

Why test it?
- Elevated levels are an early sign of negative energy balance and potential ketosis.
- Particularly useful in diabetic cats with weight loss but maintained appetite.

Reference range:
- Dogs: < 0.7 mmol/L
- Cats: < 1.0 mmol/L

For more information or to request these analyses in your next clinical profile, please contact our Customer Area team. Together, we can improve the quality of life and outcomes for diabetic pets.

Sub-category

Products in this article

A15

A15

A15 is a small size and low demanding analyser that facilitates automation of tests.

See this product

BA400

BA400

BA400 is a full automatic analyser with automatic hemolysis on whole blood samples and fast sample loading.

See this product

BA200

BA200

BA200 is a full automatic analyser with high reagent and sample capacity (88 position), the highest grade in flexibility.

See this product

BTS

BTS

BTS is a manual analyser with LED optics system, and a new intuitive and easy-to-use software that will ease your daily work in the laboratory.

See this product